Foot-and-mouth disease-Seneca bivalent virus-like particle vaccine as well as preparation method and application thereof
The invention discloses a foot-and-mouth disease-Seneca bivalent virus-like particle vaccine as well as a preparation method and application thereof, and belongs to the technical field of animal vaccines and veterinary biological products. The novel bivalent virus-like particle vaccine is prepared by taking foot-and-mouth disease (type O and type A) virus-like particles and Seneca type A virus-like particles as antigens, and the immune synergistic effect and immune efficacy of the bivalent vaccine are evaluated by determining a vaccine preparation process, immune indexes, safety parameters and the like. Experiments prove that the bivalent vaccine has the advantages of strong immunogenicity, good safety, no immune interference and the like, can achieve an immune protection effect equivalent to that of a monovalent vaccine, and is an antigen form most likely to replace a traditional inactivated vaccine. The bivalent virus-like particle vaccine is time-saving, labor-saving and cost-saving in production and application, animal stress can be reduced, the immune effect of'two prevention by one injection 'is achieved, and meanwhile, a more effective vaccine choice is provided for prevention and control of foot-and-mouth disease, Seneca and other virulent diseases..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 03. Nov. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
GUO HUICHEN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 |
---|
Patentnummer: |
CN116983402 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA019000634 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA019000634 | ||
003 | DE-627 | ||
005 | 20240126101936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240126s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA019000634 | ||
035 | |a (EPA)CN116983402 | ||
035 | |a (EPA)88530301 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a GUO HUICHEN |e verfasserin |4 aut | |
245 | 1 | 0 | |a Foot-and-mouth disease-Seneca bivalent virus-like particle vaccine as well as preparation method and application thereof |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-03, Last update posted on www.tib.eu: 2024-01-22, Last updated: 2024-01-26 | ||
520 | |a The invention discloses a foot-and-mouth disease-Seneca bivalent virus-like particle vaccine as well as a preparation method and application thereof, and belongs to the technical field of animal vaccines and veterinary biological products. The novel bivalent virus-like particle vaccine is prepared by taking foot-and-mouth disease (type O and type A) virus-like particles and Seneca type A virus-like particles as antigens, and the immune synergistic effect and immune efficacy of the bivalent vaccine are evaluated by determining a vaccine preparation process, immune indexes, safety parameters and the like. Experiments prove that the bivalent vaccine has the advantages of strong immunogenicity, good safety, no immune interference and the like, can achieve an immune protection effect equivalent to that of a monovalent vaccine, and is an antigen form most likely to replace a traditional inactivated vaccine. The bivalent virus-like particle vaccine is time-saving, labor-saving and cost-saving in production and application, animal stress can be reduced, the immune effect of'two prevention by one injection 'is achieved, and meanwhile, a more effective vaccine choice is provided for prevention and control of foot-and-mouth disease, Seneca and other virulent diseases. | ||
650 | 4 | |a bio | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a SUN SHIQI |4 aut | |
700 | 0 | |a SONG HETAO |4 aut | |
700 | 0 | |a BAI MANYUAN |4 aut | |
700 | 0 | |a DING YAOZHONG |4 aut | |
700 | 0 | |a YIN SHUANGHUI |4 aut | |
700 | 0 | |a ZHANG YUN |4 aut | |
700 | 0 | |a DONG HU |4 aut | |
700 | 0 | |a TENG ZHIDONG |4 aut | |
700 | 0 | |a ZHOU JINGJING |4 aut | |
700 | 0 | |a WU JIN'EN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 03. Nov. |
773 | 1 | 8 | |g year:2023 |g day:03 |g month:11 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88530301/publication/CN116983402A1?q=CN116983402 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 03 |c 11 |
951 | |a AR | ||
952 | |j 2023 |b 03 |c 11 |